Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Portuguese Institute of Rheumatology (IPR) is a premier non-profit healthcare and research organization located in Lisbon, Portugal, specializing in the field of rheumatology. Established in 1948, the institute provides comprehensive clinical care, including specialized consultations, diagnostic imaging, and physical rehabilitation for patients with musculoskeletal and autoimmune diseases. Beyond clinical practice, IPR is a significant hub for clinical research, frequently serving as a site for international Phase 2 and Phase 3 clinical trials in partnership with global pharmaceutical companies. The organization is also dedicated to medical training and the promotion of scientific knowledge through its publications and academic collaborations. Its multidisciplinary approach integrates patient care with cutting-edge research to improve outcomes for individuals suffering from chronic rheumatic conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Portuguese Institute of Rheumatology.